Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: A comparative study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 5, 2010, Pages 641-650

  Park, Dong Ho ^a   Shin, Jae Pil ^a   Kim, Si Yeol ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Bevacizumab; Diabetic retinopathy; Intravitreal injection; Triamcinolone acetonide; Vitrectomy

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FIBRIN FORMATION; FOLLOW UP; HEART INFARCTION; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; RETINA DETACHMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; INTRAOPERATIVE COMPLICATIONS; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 77952095607     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1247-7     Document Type: Article

References (45)

1. MA Novak TA Rice RG Michels C Auer 1984 Vitreous hemorrhage after vitrectomy for diabetic retinopathy Ophthalmology 91 1485 1489 1:STN:280:DyaL2M7htF2rsQ%3D%3D 6521989 (Pubitemid 15197020)
2. AP Schachat RT Oyakawa RG Michels TA Rice 1983 Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications Ophthalmology 90 522 530 1:STN:280:DyaL3s3nt1eqtw%3D%3D 6192378
3. FI Tolentino VN Cajita T Gancayco S Skates 1989 Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy Ophthalmology 96 1495 1500 1:STN:280:DyaK3c%2FmslGnuw%3D%3D 2587044
4. VS Hershberger JJ Augsburger RK Hutchins LA Raymond S Krug 2004 Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings Ophthalmology 111 1215 1221 10.1016/j.ophtha.2003.08.043 15177974 (Pubitemid 38737003)
5. S de Bustros BM Glaser RG Michels C Auer 1985 Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage Arch Ophthalmol 103 219 221 3883968
6. CN Koutsandrea MN Apostolopoulos DZ Chatzoulis EA Parikakis GP Theodossiadis 2001 Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage Acta Ophthalmol Scand 79 34 38 10.1034/j.1600-0420.2001. 079001034.x 1:CAS:528:DC%2BD3MXps1altA%3D%3D 11167284 (Pubitemid 32061032)
7. PP Hood TP Cotter JF Costello AP Sampson 1999 Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients Thorax 54 1075 1082 10.1136/thx.54.12.1075 1:STN:280:DC%2BD3c%2Fjs12jtA%3D%3D 10567626
8. NK Ozaki KD Beharry KC Nishihara Y Akmal JG Ang R Sheikh HD Modanlou 2002 Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia Invest Ophthalmol Vis Sci 43 1546 1557 11980873
9. CA Wilson BA Berkowitz Y Sato N Ando JT Handa E De Juan Jr 1992 Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation Arch Ophthalmol 110 1155 1159 1:CAS:528: DyaK38Xls1Cjuro%3D 1497531
10. H Faghihi A Taheri MS Farahvash MR Esfahani MT Rajabi 2008 Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial Retina 28 1241 1246 10.1097/IAE.0b013e31817d5be3 18626423
11. SY Lee HG Lee HW Chung YH Yoon JG Kim 2007 Efficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage Korean J Ophthalmol 21 208 212 10.3341/kjo.2007.21.4.208 18063884
12. JB Jonas I Kreissig R Degenring 2005 Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases Prog Retin Eye Res 24 587 611 10.1016/j.preteyeres.2005.01.004 1:CAS:528:DC%2BD2MXlvFehs7o%3D 16005407 (Pubitemid 40949559)
13. JF Arevalo J Fromow-Guerra H Quiroz-Mercado JG Sanchez L Wu M Maia MH Berrocal A Solis-Vivanco ME Farah 2007 Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the pan-American collaborative retina study group at 6-month follow-up Ophthalmology 114 743 750 10.1016/j.ophtha.2006.12.028 17398322 (Pubitemid 46483714)
14. C Haritoglou D Kook A Neubauer A Wolf S Priglinger R Strauss A Gandorfer M Ulbig A Kampik 2006 Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema Retina 26 999 1005 10.1097/01.iae.0000247165. 38655.bf 17151486 (Pubitemid 44973218)
15. R Jorge RA Costa D Calucci LP Cintra IU Scott 2006 Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study) Retina 26 1006 1013 10.1097/01.iae.0000246884.76018.63 17151487 (Pubitemid 44973219)
16. Y Oshima H Sakaguchi F Gomi Y Tano 2006 Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy Am J Ophthalmol 142 155 158 10.1016/j.ajo.2006.02.015 1:CAS:528:DC%2BD28Xms1Gktbw%3D 16815267 (Pubitemid 43946776)
17. RLD da JA Ribeiro RA Costa JC Barbosa IU Scott LL de Figueiredo-Pontes R Jorge 2009 Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study) Br J Ophthalmol 93 688 691 10.1136/bjo.2008.151233
18. Y Oshima C Shima T Wakabayashi S Kusaka F Shiraga M Ohji Y Tano 2009 Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment Ophthalmology 116 927 938 10.1016/j.ophtha.2008.11.005 19269033
19. S Rizzo F Genovesi-Ebert E Di Bartolo A Vento S Miniaci G Williams 2008 Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR) Graefes Arch Clin Exp Ophthalmol 246 837 842 10.1007/s00417-008-0774-y 1:CAS:528:DC%2BD1cXlsVGitLw%3D 18286296
20. J Yeoh C Williams P Allen R Buttery D Chiu B Clark R Essex M McCombe S Qureshi WG Campbell 2008 Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series Clin Experiment Ophthalmol 36 449 454 18942219
21. Yeung L, Liu L, Wu WC, Kuo YH, Chao AN, Chen KJ, Yang KJ, Chen TL, Lai CC (2009) Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment. Acta Ophthalmol
22. JF Arevalo M Maia HW Flynn Jr M Saravia RL Avery L Wu M Eid Farah DJ Pieramici MH Berrocal JG Sanchez 2008 Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy Br J Ophthalmol 92 213 216 10.1136/bjo.2007.127142 1:STN:280:DC%2BD1c%2FmvFWhsA%3D%3D 17965108 (Pubitemid 351224097)
23. JT Holladay 1997 Proper method for calculating average visual acuity J Refract Surg 13 388 391 1:STN:280:DyaK2svhsVSltg%3D%3D 9268940
24. MJ Hogan SJ Kimura P Thygeson 1959 Signs and symptoms of uveitis. I. Anterior uveitis Am J Ophthalmol 47 155 170 1:STN:280:DyaG1M%2FnvFCksg%3D%3D 13649855
25. RL Avery J Pearlman DJ Pieramici MD Rabena AA Castellarin MA Nasir MJ Giust R Wendel A Patel 2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy Ophthalmology 113 1695 1705 10.1016/j.ophtha.2006.05.064 17011951 (Pubitemid 44442453)
26. RL Avery DJ Pieramici MD Rabena AA Castellarin MA Nasir MJ Giust 2006 Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363 372 10.1016/j.ophtha.2005.11.019 16458968
27. E Chen CH Park 2006 Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy Retina 26 699 700 10.1097/01.iae.0000225351.87205.69 16829817 (Pubitemid 44620378)
28. K Ishikawa S Honda Y Tsukahara A Negi 2009 Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy Eye 23 108 111 10.1038/sj.eye.6702983 1:CAS:528: DC%2BD1MXlvFGhug%3D%3D 17891057
29. WR Lo SJ Kim TM Aaberg Sr C Bergstrom SK Srivastava J Yan DF Martin GB Hubbard 3rd 2009 Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (Avastin) Retina 29 926 931 10.1097/IAE.0b013e3181a8eb88 19584650
30. UB Kompella N Bandi SP Ayalasomayajula 2003 Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression Invest Ophthalmol Vis Sci 44 1192 1201 10.1167/iovs.02-0791 12601049 (Pubitemid 36297840)
31. M Nauck M Roth M Tamm O Eickelberg H Wieland P Stulz AP Perruchoud 1997 Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids Am J Respir Cell Mol Biol 16 398 406 1:CAS:528:DyaK2sXitl2jurw%3D 9115750
32. O Sawada H Kawamura M Kakinoki T Sawada M Ohji 2007 Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy Arch Ophthalmol 125 1363 1366 10.1001/archopht.125.10.1363 1:CAS:528:DC%2BD2sXht1aqurrP 17923544 (Pubitemid 47606601)
33. Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H (2008) Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Eye
34. TD Warner 1999 Relationships between the endothelin and nitric oxide pathways Clin Exp Pharmacol Physiol 26 247 252 10.1046/j.1440-1681.1999.03025.x 1:CAS:528:DyaK1MXhs12ru7o%3D 10081622 (Pubitemid 29128024)
35. MR Romano SK Gibran J Marticorena D Wong H Heimann 2009 Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage? Eur J Ophthalmol 19 618 621 19551678
36. SJ Bakri MR Snyder JM Reid JS Pulido RJ Singh 2007 Pharmacokinetics of intravitreal bevacizumab (Avastin) Ophthalmology 114 855 859 10.1016/j.ophtha.2007.01.017 17467524 (Pubitemid 46635858)
37. PM Beer SJ Bakri RJ Singh W Liu GB Peters 3rd M Miller 2003 Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 681 686 10.1016/S0161-6420(02)01969-3 12689886 (Pubitemid 36520063)
38. HS Chin TS Park YS Moon JH Oh 2005 Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes Retina 25 556 560 10.1097/00006982-200507000-00002 16077349 (Pubitemid 41077256)
39. P Summanen 1988 Neovascular glaucoma following vitrectomy for diabetic eye disease Acta Ophthalmol (Copenh) 66 110 116 10.1111/j.1755-3768.1988. tb08544.x 1:STN:280:DyaL1c3gs1Omtg%3D%3D
40. R Machemer G Blankenship 1981 Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage Ophthalmology 88 643 646 1:STN:280:DyaL3M3ntFKksQ%3D%3D 7267032
41. JB Jonas JK Hayler A Sofker S Panda-Jonas 2001 Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone J Glaucoma 10 284 287 10.1097/00061198-200108000-00007 1:STN:280:DC%2BD3MrhtVyksw%3D%3D 11558812 (Pubitemid 32781343)
42. JB Jonas JK Hayler A Sofker S Panda-Jonas 2001 Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy Am J Ophthalmol 131 468 471 10.1016/S0002-9394(00)00882-5 1:CAS:528:DC%2BD3MXisVWmtLw%3D 11292410 (Pubitemid 32273433)
43. MC Gillies M Kuzniarz J Craig M Ball W Luo JM Simpson 2005 Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract Ophthalmology 112 139 143 10.1016/j.ophtha.2004.07.017 15629834 (Pubitemid 40075333)
44. JB Jonas RF Degenring I Kreissig I Akkoyun BA Kamppeter 2005 Intraocular pressure elevation after intravitreal triamcinolone acetonide injection Ophthalmology 112 593 598 10.1016/j.ophtha.2004.10.042 15808249
45. LM Smithen MD Ober L Maranan RF Spaide 2004 Intravitreal triamcinolone acetonide and intraocular pressure Am J Ophthalmol 138 740 743 10.1016/j.ajo.2004.06.067 1:CAS:528:DC%2BD2cXpsVOkurc%3D 15531307 (Pubitemid 39452920)